Halo Pharmaceutical Revenue and Competitors

East Rutherford, NJ USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Halo Pharmaceutical's estimated annual revenue is currently $26.3M per year.(i)
  • Halo Pharmaceutical's estimated revenue per employee is $201,000

Employee Data

  • Halo Pharmaceutical has 131 Employees.(i)
  • Halo Pharmaceutical grew their employee count by -1% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5M25-11%N/AN/A
#2
$35.8M1788%N/AN/A
#3
$5.4M27-25%N/AN/A
#4
$4180M145161%$550MN/A
#5
$12.5M6215%N/AN/A
#6
$6.7M119-37%$199.6MN/A
#7
$9.4M477%N/AN/A
#8
$10.3M516%N/AN/A
#9
$106.3M52916%N/AN/A
#10
$15.5M7720%N/AN/A
Add Company

Halo Pharmaceutical, headquartered in Whippany, New Jersey contract manufactures product for several clients and is a full service FDA, (both CBER and CDER) and DEA (C2-C5) facility. The manufacturing capabilities cover all aspects of commercial production of small molecule and biological drugs, specializing in solid dosage form manufacturing and finished goods packaging.

keywords:N/A

N/A

Total Funding

131

Number of Employees

$26.3M

Revenue (est)

-1%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Halo Pharmaceutical's People

NameTitleEmail/Phone
1
ScientistReveal Email/Phone
2
Analytical ChemistReveal Email/Phone
3
Project ManagerReveal Email/Phone
4
Quality AuditorReveal Email/Phone
5
AssociateReveal Email/Phone
6
Director, EHSReveal Email/Phone
7
Sr. Manager, Solid DosageReveal Email/Phone
8
Product DevelopmentReveal Email/Phone
9
Validation SpecialistReveal Email/Phone
10
Packaging Group leaderReveal Email/Phone

Halo Pharmaceutical News

2022-04-13 - Antares Pharma to be acquired by Halozyme in $960M deal ...

The transaction has been unanimously approved by both the Halozyme (NASDAQ: HALO) and Antares boards of directors.

2022-04-13 - Halozyme bolsters drug delivery business with $960 mln ...

April 13 (Reuters) - Halozyme Therapeutics Inc (HALO. ... all-cash deal for specialty pharmaceutical company Antares Pharma Inc (ATRS.

2022-04-13 - Halozyme to Acquire Antares Pharma to Create a Specialty ...

SAN DIEGO and EWING, N.J., April 13, 2022 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") and Antares Pharma,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$15M14436%N/A
#2
$116.9M4255%N/A
#3
N/A4557%N/A
#4
$103.5M571N/AN/A
#5
$130.8M6547%N/A